Cholesterol-modified prognostic nutritional index (CPNI) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer
Jinyu Shi(Capital Medical University), Hanping Shi(Beijing Shijitan Hospital), Shiqi Lin(Nanjing University of Information Science and Technology), Chunlei Hu(Capital Medical University), Hailun Xie(Guangxi Medical University), Mengmeng Song(China Pharmaceutical University), Xin Zheng(Union Hospital), Heyang Zhang(Academy of Military Medical Sciences), Chenan Liu(Hunan University of Technology), Qi Zhang(East China University of Science and Technology), Tong Liu(Capital Medical University), Yue Chen(Shanghai University of Engineering Science), Xiangrui Li(Institute of Plant Protection), Xiaoyue Liu(Zhejiang University), Li Deng(Capital Medical University), Xiaowei Zhang(Shanghai Medical College of Fudan University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Guo‐Tian Ruan(Beijing Friendship Hospital)
Cited by 70
Related Papers
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170
A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment
|Journal of Neuroinflammation|2020|167
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer
|Frontiers in Endocrinology|2022|161
Inflammatory burden as a prognostic biomarker for cancer
|Clinical Nutrition|2022|152